WFG Advisors’s Haemonetics HAE Stock Holding History

WFG Advisors’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$1K	Hold	18	–	–	﹤0.01%	1479
2017 Q1	$1K	Hold	18	–	–	﹤0.01%	1402
2016 Q4	$1K	Hold	18	–	–	﹤0.01%	1479
2016 Q3	$1K	Hold	18	–	–	﹤0.01%	1469
2016 Q2	$1K	Hold	18	–	–	﹤0.01%	1456
2016 Q1	$1K	Hold	18	–	–	﹤0.01%	1417
2015 Q4	$1K	Hold	18	–	–	﹤0.01%	1459
2015 Q3	$1K	Hold	18	–	–	﹤0.01%	1496
2015 Q2	$1K	Sell	18 -40	-69%	-$1.69K	﹤0.01%	1568
2015 Q1	$3K	Hold	58	–	–	﹤0.01%	1473
2014 Q4	$2K	Hold	58	–	–	﹤0.01%	1842
2014 Q3	$2K	Buy	58 +40	+222%	+$1.43K	﹤0.01%	1868
2014 Q2	$1K	Hold	18	–	–	﹤0.01%	1902
2014 Q1	$1K	Sell	18 -68	-79%	-$2.6K	﹤0.01%	1891
2013 Q4	$4K	Hold	86	–	–	﹤0.01%	1800
2013 Q3	$3K	Hold	86	–	–	﹤0.01%	1841
2013 Q2	$4K	Buy	+86	New	+$3.48K	﹤0.01%	1720

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WFG Advisors's HAE Position: Q2 2017 in Review

WFG Advisors held its Haemonetics (HAE) position steady in Q2 2017 at 18 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1479.

WFG Advisors first reported a position in HAE in Q2 2013 and has held it in 17 quarters since. The position peaked at $4K in Q4 2013. 197 funds tracked by Wall St. Rank hold HAE as of Q2 2017.

WFG Advisors held 18 shares of Haemonetics worth $1K as of Q2 2017.
WFG Advisors left its Haemonetics share count unchanged in Q2 2017.
Haemonetics made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1479 holding.
WFG Advisors first reported a position in Haemonetics in Q2 2013 and has held it in 17 quarters since.
WFG Advisors's Haemonetics position peaked at $4K in Q4 2013.
197 funds tracked by Wall St. Rank held Haemonetics as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.